Literature DB >> 23603993

Serum levels of 25-hydroxy vitamin D in normal Biozzi and C57BL/6 mice and during the course of chronic relapsing experimental autoimmune encephalomyelitis (CR EAE).

Christopher Bolton1, Janet Gates, Gavin Giovannoni.   

Abstract

OBJECTIVE AND
DESIGN: The aim of the study was to examine possible variations in the levels of 25-hydroxy vitamin D [25-(OH)D] in sera from normal Biozzi and C57BL/6 mice and during the course of chronic relapsing experimental autoimmune encephalomyelitis (CR EAE). MATERIAL: Serum concentrations of 25-(OH)D were measured in normal male and female Biozzi and C57BL/6 mice, at 3-4 weeks old and 8-10 weeks old, with a minimum of six animals/group. Levels of the vitamin were also determined in CR EAE-inoculated mice, and controls, during the course of the disease using a minimum of six animals/treatment.
METHODS: Cardiac blood was collected from the groups of normal, control and CR EAE-sensitised mice and sera prepared, by centrifugation of clotted samples, and assayed for 25-(OH)D levels by chemiluminescence assay.
RESULTS: Normal male and female Biozzi and C57BL/6 mice had significantly higher levels of 25-(OH)D at 8-10 weeks old compared to concentrations at 3-4 weeks of age (P < 0.005). Also, levels of the vitamin were significantly raised in C57BL/6 male and female mice compared to values in samples from corresponding Biozzi mice. In addition, the amounts of 25-(OH)D in sera from female Biozzi and C57BL/6 mice were significantly increased compared to strain and aged-matched male mice. The CR EAE mice with acute stage disease had significantly higher 25-(OH)D levels compared to controls (P < 0.005). Vitamin concentrations fell to within controls values with the progression of CR EAE.
CONCLUSIONS: Our preliminary studies have revealed marked differences between the amounts of 25-(OH)D in sera from Biozzi and C57BL/6 mice together with clear gender bias. The investigations also show significant, but selective changes, in levels of the vitamin during the course of CR EAE that are not always associated with the neurological disease state.

Entities:  

Mesh:

Substances:

Year:  2013        PMID: 23603993     DOI: 10.1007/s00011-013-0618-z

Source DB:  PubMed          Journal:  Inflamm Res        ISSN: 1023-3830            Impact factor:   4.575


  44 in total

1.  1,25-Dihydroxyvitamin D3 acts directly on the T lymphocyte vitamin D receptor to inhibit experimental autoimmune encephalomyelitis.

Authors:  Christopher G Mayne; Justin A Spanier; Lance M Relland; Calvin B Williams; Colleen E Hayes
Journal:  Eur J Immunol       Date:  2011-02-01       Impact factor: 5.532

2.  Enhancement of 1,25-dihydroxyvitamin D3-mediated suppression of experimental autoimmune encephalomyelitis by calcitonin.

Authors:  Bryan R Becklund; Donald W Hansen; Hector F Deluca
Journal:  Proc Natl Acad Sci U S A       Date:  2009-03-12       Impact factor: 11.205

3.  Development of experimental autoimmune encephalomyelitis (EAE) in mice requires vitamin D and the vitamin D receptor.

Authors:  Yanping Wang; Steven J Marling; Jinge G Zhu; Kyle S Severson; Hector F DeLuca
Journal:  Proc Natl Acad Sci U S A       Date:  2012-05-16       Impact factor: 11.205

4.  1,25-dihydroxyvitamin D3 is a positive regulator for the two anti-encephalitogenic cytokines TGF-beta 1 and IL-4.

Authors:  M T Cantorna; W D Woodward; C E Hayes; H F DeLuca
Journal:  J Immunol       Date:  1998-06-01       Impact factor: 5.422

5.  1,25-Dihydroxyvitamin D3 reversibly blocks the progression of relapsing encephalomyelitis, a model of multiple sclerosis.

Authors:  M T Cantorna; C E Hayes; H F DeLuca
Journal:  Proc Natl Acad Sci U S A       Date:  1996-07-23       Impact factor: 11.205

6.  Vitamin D deficiency diminishes the severity and delays onset of experimental autoimmune encephalomyelitis.

Authors:  Hector F DeLuca; Lori A Plum
Journal:  Arch Biochem Biophys       Date:  2011-07-19       Impact factor: 4.013

7.  Vitamin D metabolism during pregnancy and lactation in the rat.

Authors:  B P Halloran; E N Barthell; H F DeLuca
Journal:  Proc Natl Acad Sci U S A       Date:  1979-11       Impact factor: 11.205

8.  Estrogen controls vitamin D3-mediated resistance to experimental autoimmune encephalomyelitis by controlling vitamin D3 metabolism and receptor expression.

Authors:  Faye E Nashold; Karen M Spach; Justin A Spanier; Colleen E Hayes
Journal:  J Immunol       Date:  2009-08-26       Impact factor: 5.422

9.  Deposition in and release of vitamin D3 from body fat: evidence for a storage site in the rat.

Authors:  S J Rosenstreich; C Rich; W Volwiler
Journal:  J Clin Invest       Date:  1971-03       Impact factor: 14.808

Review 10.  Vitamin D as an immune modulator in multiple sclerosis, a review.

Authors:  Joost Smolders; Jan Damoiseaux; Paul Menheere; Raymond Hupperts
Journal:  J Neuroimmunol       Date:  2008-01-04       Impact factor: 3.478

View more
  6 in total

Review 1.  Environmental Impact on Intestinal Stem Cell Functions in Mucosal Homeostasis and Tumorigenesis.

Authors:  Leonard H Augenlicht
Journal:  J Cell Biochem       Date:  2017-01-11       Impact factor: 4.429

2.  Vitamin D is a determinant of mouse intestinal Lgr5 stem cell functions.

Authors:  Karina Peregrina; Michele Houston; Cecilia Daroqui; Elena Dhima; Rani S Sellers; Leonard H Augenlicht
Journal:  Carcinogenesis       Date:  2014-10-24       Impact factor: 4.944

3.  High dose vitamin D exacerbates central nervous system autoimmunity by raising T-cell excitatory calcium.

Authors:  Darius Häusler; Sebastian Torke; Evelyn Peelen; Thomas Bertsch; Marija Djukic; Roland Nau; Catherine Larochelle; Scott S Zamvil; Wolfgang Brück; Martin S Weber
Journal:  Brain       Date:  2019-09-01       Impact factor: 13.501

4.  Vitamin Supplementation at the Time of Immunization with a Cold-Adapted Influenza Virus Vaccine Corrects Poor Mucosal Antibody Responses in Mice Deficient for Vitamins A and D.

Authors:  S L Surman; R R Penkert; B G Jones; R E Sealy; J L Hurwitz
Journal:  Clin Vaccine Immunol       Date:  2016-01-06

5.  Vitamin D as Supplemental Therapy for Pneumocystis Pneumonia.

Authors:  Guang-Sheng Lei; Chen Zhang; Michelle K Zimmerman; Chao-Hung Lee
Journal:  Antimicrob Agents Chemother       Date:  2015-12-14       Impact factor: 5.191

6.  Genetic background can result in a marked or minimal effect of gene knockout (GPR55 and CB2 receptor) in experimental autoimmune encephalomyelitis models of multiple sclerosis.

Authors:  Sofia Sisay; Gareth Pryce; Samuel J Jackson; Carolyn Tanner; Ruth A Ross; Gregory J Michael; David L Selwood; Gavin Giovannoni; David Baker
Journal:  PLoS One       Date:  2013-10-09       Impact factor: 3.240

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.